New Mexico Cancer Center’s cutting-edge approach to diagnosing and treating prostate cancer. With a team of dedicated specialists, their personalized treatment plans focus on the most ...

Myriad Genetics faces a tough year ahead with new policy changes. Learn why MYGN stock has cratered and if it's poised for ...

Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.

PSMA-PET/CT findings were positive in 84% of the patients. PSMA-PET/CT detected distant metastatic disease in 46% of patients, including 34% of patients after RP, 56% after definitive RT, and 60% ...

Biobot Surgical announced today that it received CE mark for its Mona Lisa 2.0 surgical robotic platform for urology ...

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

Prostate cancer remains a significant health concern for men. Here's how to take charge of your prostate health, ...

New AI model using XGBoost accurately diagnoses prostate cancer in low-PSA patients, reducing biopsy need and enhancing ...

In a major new policy shift, the Department of Veterans Affairs is making it easier for a large group of people who serve the ...

Keck Medicine of USC is participating in a national, multisite clinical trial examining if a water vapor system that uses ...

Researchers conducted a retrospective study using data from 182 subjects with high-risk recurrent prostate cancers.

Most prostate cancers develop in the peripheral zone of the prostate, making them palpable on digital rectal examination when sufficiently large. However, palpable cancers are often already ...